These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

241 related articles for article (PubMed ID: 24965234)

  • 1. Nonalcoholic fatty liver disease after pancreatoduodenectomy is closely associated with postoperative pancreatic exocrine insufficiency.
    Nakagawa N; Murakami Y; Uemura K; Sudo T; Hashimoto Y; Kondo N; Sasaki H; Okano K; Sueda T
    J Surg Oncol; 2014 Nov; 110(6):720-6. PubMed ID: 24965234
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Remnant pancreatic parenchymal volume predicts postoperative pancreatic exocrine insufficiency after pancreatectomy.
    Okano K; Murakami Y; Nakagawa N; Uemura K; Sudo T; Hashimoto Y; Kondo N; Takahashi S; Sueda T
    Surgery; 2016 Mar; 159(3):885-92. PubMed ID: 26603844
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Identification of risk factors for pancreatic exocrine insufficiency after pancreaticoduodenectomy using a 13C-labeled mixed triglyceride breath test.
    Hirono S; Murakami Y; Tani M; Kawai M; Okada K; Uemura K; Sudo T; Hashimoto Y; Nakagawa N; Kondo N; Yamaue H
    World J Surg; 2015 Feb; 39(2):516-25. PubMed ID: 25318451
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Reduced pancreatic parenchymal thickness indicates exocrine pancreatic insufficiency after pancreatoduodenectomy.
    Nakamura H; Murakami Y; Uemura K; Hayashidani Y; Sudo T; Ohge H; Sueda T
    J Surg Res; 2011 Dec; 171(2):473-8. PubMed ID: 20605585
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Predictive factors for exocrine pancreatic insufficiency after pancreatoduodenectomy with pancreaticogastrostomy.
    Nakamura H; Murakami Y; Uemura K; Hayashidani Y; Sudo T; Ohge H; Sueda T
    J Gastrointest Surg; 2009 Jul; 13(7):1321-7. PubMed ID: 19415402
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Histological loss of pancreatic exocrine cells correlates with pancreatic exocrine function after pancreatic surgery.
    Yuasa Y; Murakami Y; Nakamura H; Uemura K; Ohge H; Sudo T; Hashimoto Y; Nakashima A; Hiyama E; Sueda T
    Pancreas; 2012 Aug; 41(6):928-33. PubMed ID: 22781909
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Perioperative Computed Tomography Assessments of the Pancreas Predict Nonalcoholic Fatty Liver Disease After Pancreaticoduodenectomy.
    Ohgi K; Okamura Y; Yamamoto Y; Ashida R; Ito T; Sugiura T; Aramaki T; Uesaka K
    Medicine (Baltimore); 2016 Feb; 95(6):e2535. PubMed ID: 26871772
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Do pancrelipase delayed-release capsules have a protective role against nonalcoholic fatty liver disease after pancreatoduodenectomy in patients with pancreatic cancer? A randomized controlled trial.
    Satoi S; Sho M; Yanagimoto H; Yamamoto T; Akahori T; Kinoshita S; Nagai M; Hirooka S; Yamaki S; Nishiwada S; Ryota H; Ikeda N; Nakajima Y; Kon M
    J Hepatobiliary Pancreat Sci; 2016 Mar; 23(3):167-73. PubMed ID: 26748629
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of pancrelipase on nonalcoholic fatty liver disease after pancreaticoduodenectomy.
    Nagai M; Sho M; Satoi S; Toyokawa H; Akahori T; Yanagimoto H; Yamamoto T; Hirooka S; Yamaki S; Kinoshita S; Nishiwada S; Ikeda N; Kwon AH; Nakajima Y
    J Hepatobiliary Pancreat Sci; 2014 Mar; 21(3):186-92. PubMed ID: 23798362
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pancrelipase with branched-chain amino acids for preventing nonalcoholic fatty liver disease after pancreaticoduodenectomy.
    Yamazaki S; Takayama T; Higaki T; Moriguchi M; Yoshida N; Miyazaki T; Teshima Y
    J Gastroenterol; 2016 Jan; 51(1):55-62. PubMed ID: 25904096
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Usefulness of a 13C-labeled mixed triglyceride breath test for assessing pancreatic exocrine function after pancreatic surgery.
    Nakamura H; Morifuji M; Murakami Y; Uemura K; Ohge H; Hayashidani Y; Sudo T; Sueda T
    Surgery; 2009 Feb; 145(2):168-75. PubMed ID: 19167971
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The impact of postoperative adjuvant chemotherapy on the development of nonalcoholic fatty liver disease after pancreatoduodenectomy.
    Nishikawa M; Aosasa S; Moriya T; Noro T; Hase K; Yamamoto J
    J Surg Res; 2016 Sep; 205(1):127-35. PubMed ID: 27621009
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Factors that predict the occurrence of and recovery from non-alcoholic fatty liver disease after pancreatoduodenectomy.
    Sato T; Matsuo Y; Shiga K; Morimoto M; Miyai H; Takeyama H
    Surgery; 2016 Aug; 160(2):318-30. PubMed ID: 27211602
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Paradoxical impact of the remnant pancreatic volume and infectious complications on the development of nonalcoholic fatty liver disease after pancreaticoduodenectomy.
    Sato R; Kishiwada M; Kuriyama N; Azumi Y; Mizuno S; Usui M; Sakurai H; Tabata M; Yamada T; Isaji S
    J Hepatobiliary Pancreat Sci; 2014 Aug; 21(8):562-72. PubMed ID: 24824077
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Development of nonalcoholic fatty liver disease (NAFLD) and nonalcoholic steatohepatitis (NASH) after pancreaticoduodenectomy: proposal of a postoperative NAFLD scoring system.
    Kato H; Isaji S; Azumi Y; Kishiwada M; Hamada T; Mizuno S; Usui M; Sakurai H; Tabata M
    J Hepatobiliary Pancreat Sci; 2010 May; 17(3):296-304. PubMed ID: 19809782
    [TBL] [Abstract][Full Text] [Related]  

  • 16. New onset non-alcoholic fatty liver disease after resection of pancreatic neuroendocrine tumors.
    Mackay TM; Genç CG; Takkenberg RB; Besselink MG; Somers I; Nieveen van Dijkum EJM
    J Surg Oncol; 2018 Jun; 117(7):1548-1555. PubMed ID: 29572825
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluation of predictive factors in patients with nonalcoholic fatty liver disease after pancreaticoduodenectomy.
    Ito Y; Kenmochi T; Shibutani S; Egawa T; Hayashi S; Nagashima A; Kitagawa Y
    Am Surg; 2014 May; 80(5):500-4. PubMed ID: 24887731
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Sarcopenia is closely associated with pancreatic exocrine insufficiency in patients with pancreatic disease.
    Shintakuya R; Uemura K; Murakami Y; Kondo N; Nakagawa N; Urabe K; Okano K; Awai K; Higaki T; Sueda T
    Pancreatology; 2017; 17(1):70-75. PubMed ID: 27743711
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Radiomics-based prediction of nonalcoholic fatty liver disease following pancreatoduodenectomy.
    Fujii T; Iizawa Y; Kobayashi T; Hayasaki A; Ito T; Murata Y; Tanemura A; Ichikawa Y; Kuriyama N; Kishiwada M; Sakuma H; Mizuno S
    Surg Today; 2024 Aug; 54(8):953-963. PubMed ID: 38581555
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Three-dimensional remnant pancreatic volume ratio indicates postoperative pancreatic exocrine insufficiency in pancreatic cancer patients after distal pancreatectomy.
    Miyamoto R; Inagaki Y; Ikeda N; Oda T
    Pancreatology; 2020 Jul; 20(5):867-874. PubMed ID: 32654989
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.